Skip to main content

Cardiology MCQ 70

Q. All of the following have shown mortality benefit in heart failure except?
A. Eplerenone
B. Enalapril
C. Digoxin
D. Metoprolol


Answer: C. Digoxin

Explanation:
Drugs which have shown mortality benefit in patients with heart failure with reduced ejection fraction (HFrEF) are-
1. Beta blockers
2. ACE inhibitors
3. Angiotensin receptor blockers
4. Aldosterone antagonist

Digoxin did not show any survival advantage in these patients.

None of drugs till date have shown mortality benefit in patients with heart failure with preserved ejection fraction (HFpEF).

Comments

Popular posts from this blog

ECG Spotter

What is the diagnosis? Click the button below to view answer: Show Answer

MCQ

 Cardiology MCQ Q. Which of the following leads is not an inferior lead in ECG? A. Lead II B. Lead III C. Lead aVF D. Lead aVR Click the button below to view answer Show answer Correct answer is option D. Lead aVR

ST segment and T wave changes

What is the cause of ST changes and T wave inversions in this ECG? Should the patient be taken to Cath lab for coronary angiography? Show Answer These ST segment and T wave changes are secondary to left ventricular hypertrophy. There are classical features of left ventricular hypertrophy in this ECG which should not be missed. Hence, if the patient doesn't have any other features which suggest ischemia, then he should undergo evaluation for cause of left ventricular hypertrophy. The most common cause for left ventricular hypertrophy is hypertension.